Mika Pharma GmbH   Report issue

For profit Phase 3
Founded: Ludwigshafen Germany (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2007
NCT00546832
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

celecoxib (celebrex) (2 trials)

diclofenac (voltaren) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2